Gary Wilkinson

Gary Wilkinson

Bayer Crop Science - Missouri / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4402147
-
person_outline Gary Wilkinson's MOST POPULAR ARTICLES
1-) Discovery and characterization of AZD6738, a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agentKM Foote, JWM Nissink, T McGuire, P Turner, S Guichard, JWT Yates, ...Journal of Medicinal Chemistry 61 (22), 9889-9907, 20181512018
2-) First-in-human trial of the oral ataxia telangiectasia and Rad3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumorsDSP Tan, J de Bono, A Caldwell, R, Terbuch, BC Goh, V Heong, N Haris, ...Asian Society of Gynecologic Oncology - 6th Biennial Meeting, 20191172019
3-) First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due …S Postel-Vinay, K Herbschleb, C Massard, V Woodcock, JC Soria, ...European Journal of Cancer 109, 103-110, 2019732019
4-) Drug–drug interaction potential of darolutamide: in vitro and clinical studiesC Zurth, M Koskinen, R Fricke, O Prien, T Korjamo, K Graudenz, K Denner, ...European Journal of Drug Metabolism and Pharmacokinetics 44, 747-759, 2019902019
5-) Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agentGP Wilkinson, JP Taylor, S Shnyder, P Cooper, PW Howard, DE Thurston, ...Investigational New Drugs 22, 231-240, 2004822004